Official Statistics

Cardiovascular disease profiles: short statistical commentary

Published 2 December 2025

Applies to England

© Crown copyright 2025

This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.

Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.

This publication is available at https://www.gov.uk/government/statistics/cardiovascular-disease-profiles-december-2025-update/cardiovascular-disease-profiles-short-statistical-commentary

What’s new

The following indicators have been updated:

  • monitoring and treatment for chronic kidney disease (CKD), including kidney replacement therapy (KRT)
  • monitoring and treatment of hypertension and those with a high risk of developing cardiovascular disease (CVD)
  • hospital admissions for coronary heart disease (CHD), heart failure and stroke
  • mortality for CHD, heart failure and stroke, including premature (under 75) mortality
  • care processes for stroke prevention and ongoing management

The indicators were updated with data covering one or some of the following geographies:

  • England
  • local authority
  • integrated care board (ICB)
  • sub-integrated care board (sub-ICB)
  • regional area

Introduction

The CVD profile brings together data on the pathway of care and the outcomes for CVD, including:

  • primary care and management of the disease and its risk conditions
  • emergency care
  • hospitalisation
  • acute care procedures (including KRT)
  • mortality

By presenting disease outcomes and risk factors, these tools provide a single summary of the burden of CVD to:

  • bring together data on the pathway of healthcare in one tool to enable users to access and use the intelligence more easily
  • provide data for health professionals and local public health colleagues when assessing the impact of the disease on their local population and making decisions about services
  • support users to identify and address inequalities in care between areas

Main findings

This update shows:

  • hospital admission rates for CHD have decreased by 46% from the financial year ending March 2005 to the financial year ending March 2025
  • from 2022 to 2024 CHD premature mortality rates per 100,000 people have reduced from 41.8 to 39.1
  • in England the KRT acceptance rate (6 years combined from 2018 to 2023) remained stable, with little change from the previous year’s rate (2017 to 2022)

Detailed findings

Heart disease and heart failure

In the financial year ending March 2025 there were around 1.9 million people (3%) with a general practice (GP) diagnosis of CHD in England. The rate of people in England with a recorded GP diagnosis of CHD has decreased almost 0.5 percentage points since the financial year ending March 2010.

Hospital admission rates for CHD have decreased by 46% from the financial year ending March 2005 to the financial year ending March 2025. There was also a 3.2-fold difference in the highest and lowest admission rates for CHD between local authorities (which comprise counties and unitary authorities) in England in the financial year ending March 2025. The highest rate was 696.5 per 100,000 population in Luton and the lowest was 215.3 per 100,000 population in Wokingham.

The range in admission rates for heart failure between local authorities is larger than CHD, with a 4.8-fold difference between local authorities in England. The highest rate was 390.2 per 100,000 population in Liverpool and the lowest was 80.8 per 100,000 in Rutland.

The rate of premature mortality from CHD in England in 2024 is still higher than the lowest recorded rate of premature mortality in 2019. However, it has decreased since 2023 to 39.1 in 2024.

Stroke

In the financial year ending March 2025 there were around 1.2 million people (1.9%) with a GP diagnosis of stroke or transient ischaemic attack (TIA) in England. The number of people with a recorded GP diagnosis of stroke or TIA in England has risen 0.2 percentage points since the financial year ending March 2010.

Kidney disease

In the financial year ending March 2025 there were around 2.4 million people (4.6%) aged 18 years and over with a GP diagnosis of CKD in England. This is an increase from 2.2 million people from the previous year.

The most recent KRT data is from 2023. Kidney transplants continued as the most common KRT treatment modality (56%), while 38% of people received in-hospital dialysis and 7% received home-based dialysis. There was little change in the modality breakdown between 2022 and 2023.

Breakdowns by sex of KRT treatment measures have been introduced for the 2023 data. More men than women start treatment for kidney failure, but there is little difference in the treatment modalities between men and women.

Further information

Further details about the profile methodology are available within the definitions section of the online version of the CVD disease profile.

For queries relating to this document, please contact: ncvin-ohid@dhsc.gov.uk.

Back to top